Reactogenicity and safety of ChAd155-vectored respiratory syncytial virus (RSV) vaccine (ChAd155-RSV) administered at different dose levels in infants aged 6–7 months
39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), Cenevre, Switzerland, 24 - 29 May 2021, (Full Text)
- Publication Type: Conference Paper / Full Text
- City: Cenevre
- Country: Switzerland
- Dokuz Eylül University Affiliated: Yes